Dr. Friba Nurmukhamma | Medicine | Best Researcher Award
Khoja Akhmet Yassawi International Kazakh-Turkish University | Kazakhstan
Dr. Friba NurmukhammadNasrullakyzy is a cardiologist, senior researcher, and PhD scholar specializing in cardiovascular pathology, with a particular focus on coronary artery disease (CAD), stenting, and post-coronary artery bypass grafting (CABG) outcomes. Her research explores the mechanisms of high residual platelet reactivity (HRPR) and dyslipidemia, contributing to improved treatment algorithms and predictive models aimed at reducing mortality in patients with complex cardiovascular conditions. Dr. Friba’s innovative work integrates clinical insights with advanced diagnostic methodologies and personalized therapeutic approaches, emphasizing non-statin therapies, platelet reactivity modulation, and functional diagnostics in cardiology. She has authored multiple peer-reviewed publications indexed in Scopus and other scientific databases, reflecting a growing international research presence. Her Scopus h-index is 3, and her research impact is further supported by citations across both Scopus and Google Scholar databases. Dr. Friba’s current projects involve developing mortality prediction scales and individualized treatment algorithms for patients with HRPR, aiming to advance precision medicine in cardiology. Her scientific contributions underscore her commitment to translational cardiovascular research and her role in fostering evidence-based practices within clinical cardiology.
Profile
Scopus | ORCID
Featured Publications
Mussagaliyeva, A., Zhangelova, S., Danyarova, L., Nurmukhammad, F., Kapsultanova, D., Sakhov, O., Rustamova, F., Sugraliyev, A., & Akhmentayeva, D. (2025). Residual platelet reactivity and dyslipidemia in post-CABG patients undergoing repeat revascularization: Insights from Kazakhstan. Diseases, 13(11), 365.
Nurmukhammad, F. N., Zhangelova, S. B., & Kapsultanova, D. A. (2025). Non-statin therapy in patients with elevated LDL-C and high platelet reactivity: A narrative review. Medical Journal of Malaysia, 80(2), 258–265.
Zhangelova, S. B., Nurmukhammad, F. N., & Nurdinov, N. (2023). High residual platelet reactivity as a predictor of atherothrombosis in patients with coronary heart disease. Science and Healthcare, 25(3), 25–31.
Mussagaliyeva, A., Zhangelova, S., Nurmukhammad, F., & Kapsultanova, D. (2025). Residual platelet reactivity and dyslipidemia in post-CABG patients: Preprint insights from Kazakhstan. Preprints, 2025(09), 2498.